Searched for
PIRAMAL PHARMA LIMITED
Swara Baby files DRHP with Sebi for Rs 1,000 crore IPOSwara Baby has filed its DRHP with Sebi for a Rs 1,000 crore IPO, comprising a Rs 500 crore fresh issue and Rs 500 crore OFS. The hygiene p...- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsFrom a macro perspective, it is clearly a good time to be bullish. But as valuations remain high in parts of the market despite the recent ...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27% in 1 yearAfter the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- Should you buy the dip? Strategist Anand James shares his weekly stock strategyMarket expert Anand James suggests caution following recent volatility. He notes the Nifty needs to break above 24,140 for a confirmed upsw...
- Exploring the Growth Potential of the Indian Pharmaceutical SectorThe Indian pharmaceutical sector is poised for significant growth, driven by favorable trade agreements and increasing global demand for ge...
- Mileen Vasudeo’ 2 stock recommendations in this marketMileen Vasudeo says: “Unless and until, Nifty breached 20,850 which was last week’s low, there is a fair chance Nifty is likely to head hig...
- After a tough year, Piramal Pharma hopes to regain vigour in 2nd halfPiramal Pharma chairperson Nandini Piramal in an interview to ET said the company is aiming for mid-teen revenue growth and a meaningful im...
- Pickup in contract manufacturing biz set to drive growth: Piramal Pharma"During the year (FY23), the customer decision-making got delayed due to macro-economic environment and pipeline prioritisation based on li...
- Piramal Pharma gets locked in lower circuitThe Ajay Piramal entity’s listing follows the demerger from parent Piramal Enterprises (PEL) as part of an exercise to simplify its structu...
- Piramal Pharma lists share on BSE, NSEIn October 2021, the board of directors of PEL approved the demerger of the pharmaceuticals business and simplification of the corporate st...
- Piramal Pharma shares hit 5% lower circuit after listingEarlier last week, the company obtained a go-ahead from the National Company Law Tribunal (NCLT) for the listing of its equity shares. Furt...
- Piramal Enterprises Q2 results: Net profit drops by 32% due to DHFL costThe non-banking finance company incurred an exceptional cost of Rs 153 crore, which is primarily on account of DHFL. Without this, the net ...
- Piramal Enterprise gets board nod for demerger and listing of pharma businessThe pharmaceuticals business will get vertically demerged from Piramal Enterprises and consolidated under Piramal Pharma Ltd (PPL), the gro...
- Piramal Pharma to buy API maker Hemmo PharmaPiramal Pharma Solutions (PPS), the Contract Development and Manufacturing Organization (CDMO) of Piramal Pharma Limited, will acquire API ...
- Piramal prepays Barclays Bank loanThe loan was backed by interest income arising out of Piramal's real estate loans given to Macrotech Developers, formerly known as Lodha De...
- Ajay Piramal’s glass business up for grabs in likely $1 billion saleGlobal buyout funds such as KKR, Advent, Carlyle, TPG and Blackstone, investment companies like Temasek and global rivals such as Saverglas...
- Carlyle picks up 20% stake in Piramal pharma biz for $490 mnThe 20% stake sale values Piramal’s pharma business at Rs 20,000 crore.
- Sanofi Aventis's Piramal plans fall throughFrench pharma major Sanofi Aventis's plans to acquire a majority stake in Mumbai-based Piramal Healthcare has fallen through due to differe...
Load More
